id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-323538-9dlr6kqh	Malard, Florent	COVID-19 outcomes in patients with hematologic disease	2020-05-06		.txt	text/plain	1600	84	45	To date, very few data are available on COVID-19 outcomes in patients with hematologic diseases. Here we describe the demographic characteristics, coexisting conditions, imaging findings, and outcomes among patients with hematologic disease and COVID-19 infection. We included all consecutive adult patients with a hematologic disease admitted to the Hematology Department (inpatient and outpatient admissions) of the Saint-Antoine-Hospital, AP-HP, Paris, France, with laboratoryconfirmed COVID-19 infection between March 9 and April 4, 2020 and with at least 10 days of follow-up. As of April 16, 2020, with a median follow-up since symptom onset of 29 days (range, 14-40), 13 of the 18 patients (52%) developed acute respiratory distress syndrome (ARDS) [9] and 6 received mechanical ventilation ( Supplementary Fig. 1) . This study highlighted the following observations: patients with a hematologic malignancy harbored a higher risk of developing a severe form of COVID-19 with ARDS, requiring mechanical ventilation, compared to those in the general French population without an underlying medical condition [1] .	./cache/cord-323538-9dlr6kqh.txt	./txt/cord-323538-9dlr6kqh.txt